Birdwatch Archive

Birdwatch Note Rating

2024-09-15 11:39:24 UTC - NOT_HELPFUL

Rated by Participant: E102FB757FEA7B24B1C6A27E8BE42CCB01D7DF5A87F54B93D3A4133829A79DF6
Participant Details

Original Note:

Cierto es que está financiado en España para tumores HER2 positivos, pero no se quiere financiar para la indicación en tumores HER2-low, a pesar de haber sido aprobada por la EMA y estarlo en muchos países de la UE. https://www.vallhebron.com/es/actualidad/noticias/un-nuevo-farmaco-oral-reduce-de-forma-significativa-el-riesgo-de-progresion-del-tumor-en-pacientes-con-cancer-de-mama-er-her2 https://www.google.com/amp/s/www.larazon.es/sociedad/sanidad-niega-financiacion-farmaco-revolucionario-frente-cancer-mama_2024061066665e5ffc83ee0001db82c6.html%3foutputType=amp

All Note Details

Original Tweet

All Information

  • noteId - 1819650240514793889
  • participantId -
  • raterParticipantId - E102FB757FEA7B24B1C6A27E8BE42CCB01D7DF5A87F54B93D3A4133829A79DF6
  • createdAtMillis - 1726400364824
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 1
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1819650240514793889E102FB757FEA7B24B1C6A27E8BE42CCB01D7DF5A87F54B93D3A4133829A79DF6